Thiamphenicol glycinate hydrochloride
CAS: 2611-61-2
Ref. 3D-FT71717
1g | Discontinued | ||
250mg | Discontinued | ||
500mg | Discontinued |
Product Information
- (2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-[4-(methylsulfonyl)phenyl]propyl glycinate hydrochloride (1:1)
- (2S,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-[4-(methylsulfonyl)phenyl]propyl glycinate hydrochloride
- 2-((Dichloroacetyl)amino)-3-hydroxy-3-(4-(methylsulphonyl)phenyl)propyl (R-(R*,R*))aminoacetate monohydrochloride
- Glycine, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-[4-(methylsulfonyl)phenyl]propyl ester, hydrochloride (1:1)
- Glycine, (2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-[4-(methylsulfonyl)phenyl]propyl ester, monohydrochloride
- Glycine, 2-[(dichloroacetyl)amino]-3-hydroxy-3-[4-(methylsulfonyl)phenyl]propyl ester, monohydrochloride, [R-(R*,R*)]-
- Glycine, alpha-ester with D-threo-(+)-2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)acetamide, hydrochloride
- Glycine, α-ester with 2,2-dichloro-N-[β-hydroxy-α-(hydroxymethyl)-p-(methylsulfonyl)phenethyl]acetamide, monohydrochloride, <span class="text-smallcaps">D</span>-threo-(+)-
- Glycine, α-ester with <span class="text-smallcaps">D</span>-threo-(+)-2,2-dichloro-N-[β-hydroxy-α-(hydroxymethyl)-p-(methylsulfonyl)phenethyl]acetamide, monohydrochloride
- Neomyson G
- See more synonyms
- Neomyson G HCl
- Neomyson G hydrochloride
- TPG hydrochloride
- Thiophenicol glycinate
- Thiophenicol glycinate hydrochloride
- Urfamicin hydrochloride
- Glycine, α-ester with 2,2-dichloro-N-[β-hydroxy-α-(hydroxymethyl)-p-(methylsulfonyl)phenethyl]acetamide, monohydrochloride, D-threo-(+)-
Thiamphenicol is a synthetic antimicrobial agent that is used to treat infections caused by gram-negative bacteria. It has a broad spectrum of activity, including the treatment of chlamydia and other sexually transmitted infections. Thiamphenicol has been shown to be effective in treating infectious diseases such as bronchitis, maxillary sinusitis and bacterial gastroenteritis. It is a prodrug that is hydrolyzed after administration to its active form, chloramphenicol succinate. The pharmacokinetic properties of thiamphenicol are determined by serum levels and renal function.